CHAPEL HILL, N.C., Feb. 4, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP) today announced that Prabhavathi Fernandes, Ph.D., chief executive officer of Cempra, will present at the BIO CEO & Investor Conference at 1 p.m. EST, Tuesday, Feb. 11, and at the 2014 Leerink Global Healthcare Conference at 2:40 p.m. EST, Wednesday, Feb. 12. Both conferences will take place at The Waldorf Astoria New York in New York City. Dr. Fernandes will discuss the company’s two differentiated antibiotics, solithromycin (CEM-101) for community-acquired bacterial pneumonia and TAKSTA (CEM-102 or fusidic acid) for the chronic, oral treatment of Gram-positive pathogens including methicillin-resistant S. aureus (MRSA) in prosthetic joint infections.
Help employers find you! Check out all the jobs and post your resume.
